Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison in TAP block for open inguinal herniorrhaphy
IRCT20190421043336N1Phase 4Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine and bupivacaine in postoperative pain (3 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Reported pain level and Complications and side effects. Started Jul 2019; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190421043336N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190421043336N1.